Tag: Recce Pharmaceuticals

Browse exclusive Tags!

Australian Government Awards Recce Pharmaceuticals $191M R&D Finding, Boosting Global Anti-Infective Program

Recce Pharmaceuticals awarded $191M R&D funding from Australian government, boosting global anti-infective program. Major step in combating antibiotic resistance.

Canadian Patent Office Grants Recce Pharmaceuticals New Family Four Patent for Anti-Infectives, Canada

Recce Pharmaceuticals has been granted a new patent in Canada for its anti-infective drugs, extending its market exclusivity until 2041. The patent covers a range of bacterial and viral pathogens, bolstering the company's commitment to innovation in combating antibiotic resistance and emerging viral threats.

Recce Pharmaceuticals Approved for Faster Infusion Rate in Promising Anti-Infective Clinical Trial

Recce Pharmaceuticals accelerates clinical trial with faster infusion rate, revolutionizing treatment for UTIs and sepsis.

Recce Pharma’s R327 Gel Shows Promise in Fighting Antibiotic-Resistant Bacteria, Australia

Recce Pharma's R327 Gel shows promise in combating antibiotic-resistant bacteria. An important step toward fighting antibiotic resistance.

Popular

Recce Pharmaceuticals Completes Safe Dosing of R327 in UTI Clinical Trial, Australia

Recce Pharmaceuticals achieves safe dosing in UTI trial, a significant milestone in the development of synthetic anti-infectives. Learn more.

Canadian Patent Office Grants Recce Pharmaceuticals New Family Four Patent for Anti-Infectives, Canada

Recce Pharmaceuticals has been granted a new patent in Canada for its anti-infective drugs, extending its market exclusivity until 2041. The patent covers a range of bacterial and viral pathogens, bolstering the company's commitment to innovation in combating antibiotic resistance and emerging viral threats.

Recce Pharma’s R327 Gel Shows Promise in Fighting Antibiotic-Resistant Bacteria, Australia

Recce Pharma's R327 Gel shows promise in combating antibiotic-resistant bacteria. An important step toward fighting antibiotic resistance.

Australian Government Awards Recce Pharmaceuticals $191M R&D Finding, Boosting Global Anti-Infective Program

Recce Pharmaceuticals awarded $191M R&D funding from Australian government, boosting global anti-infective program. Major step in combating antibiotic resistance.

Subscribe

spot_imgspot_img